Skip to main navigation
Tenaya Therapeutics
  • Careers at Tenaya
  • Contact Us
  • Leadership
  • Our Science
    • Platforms
    • Capabilities
    • Collaborations
    • Publications & Presentations
  • Our Programs
    • Pipeline
    • Programs
  • Patients & Families
    • Overview
    • Tenaya Approach
    • Advocacy Partners
    • Studies
    • Our Inspiration
    • Resources
  • Investors
    • News & Events
      • Press Releases
      • In the News
      • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts

Investor Portal

Cell and Gene Collaborative: Time Well-Spent: Embracing Opportunity Costs In Gene Therapy Manufacturing

Apr 11, 2022
PDF Version

Tenaya CTO Kee-Hong Kim discusses the importance of time management and its role in empowering efficient manufacturing in this second part of his interview with Anna Rose Welch of Cell and Gene Collaborative.

Read More

Click here for part one of the interview.

RSS Feeds
Email Alerts
Contact IR
Print

Privacy Policy | Terms of Use    © 2023 Tenaya Therapeutics. All rights reserved.